Rfg Advisory, LLC Gilead Sciences, Inc. Transaction History

Rfg Advisory, LLC

$2.86 Billion
Q1 2024

A detailed history of Rfg Advisory, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Rfg Advisory, LLC holds 22,514 shares of GILD stock, worth $1.54 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

22,514

Previous 19,265 16.86%

Holding current value

$1.54 Million

Previous $1.56 Million 5.71%

% of portfolio

0.06%

Previous 0.06%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	BUY	$71.58 - $87.29 $232,563 - $283,605	3,249 Added 16.86%	22,514 $1.65 Million
Q4 2023 Jan 25, 2024	BUY	$73.27 - $83.09 $162,586 - $184,376	2,219 Added 13.02%	19,265 $1.56 Million
Q3 2023 Oct 16, 2023	SELL	$73.94 - $80.67 $275,944 - $301,060	-3,732 Reduced 17.96%	17,046 $1.28 Million
Q2 2023 Aug 03, 2023	BUY	$76.01 - $86.7 $117,131 - $133,604	1,541 Added 8.01%	20,778 $1.6 Million
Q1 2023 May 09, 2023	BUY	$77.31 - $88.08 $21,260 - $24,222	275 Added 1.45%	19,237 $1.6 Million

Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $17,075 - $24,514	-274 Reduced 1.42%	18,962 $1.63 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $56,265 - $64,269	945 Added 5.17%	19,236 $1.58 Million
Q2 2022 Aug 09, 2022	BUY	$57.72 - $65.01 $485,021 - $546,279	8,403 Added 84.98%	18,291 $1.12 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $2,085 - $2,612	-36 Reduced 0.36%	9,888 $588,000
Q4 2021 Feb 02, 2022	BUY	$64.88 - $73.64 $76,039 - $86,306	1,172 Added 13.39%	9,924 $721,000
Q3 2021 Oct 19, 2021	BUY	$67.69 - $73.03 $7,852 - $8,471	116 Added 1.34%	8,752 $611,000
Q2 2021 Jul 29, 2021	SELL	$63.47 - $69.35 $1,967 - $2,149	-31 Reduced 0.36%	8,636 $595,000
Q1 2021 Apr 19, 2021	SELL	$60.0 - $68.46 $112,740 - $128,636	-1,879 Reduced 17.82%	8,667 $560,000
Q4 2020 Feb 02, 2021	BUY	$56.65 - $64.55 $168,703 - $192,229	2,978 Added 39.35%	10,546 $665,000
Q3 2020 Oct 13, 2020	BUY	$62.1 - $78.08 $36,576 - $45,989	589 Added 8.44%	7,568 $478,000
Q2 2020 Aug 03, 2020	BUY	$72.34 - $84.0 $246,607 - $286,356	3,409 Added 95.49%	6,979 $537,000
Q1 2020 Apr 17, 2020	BUY	$62.63 - $80.22 $22,734 - $29,119	363 Added 11.32%	3,570 $267,000
Q4 2019 Jan 22, 2020	BUY	$61.62 - $67.78 $197,615 - $217,370	3,207 New	3,207 $208,000
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $213,034 - $235,152	-3,408 Closed	0 $0
Q2 2019 Aug 23, 2019	BUY	$61.87 - $69.38 $210,852 - $236,447	3,408 New	3,408 $231,000
Q1 2019 Apr 25, 2019	SELL	$62.53 - $70.05 $402,880 - $451,332	-6,443 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $69,499 - $90,692	-1,148 Reduced 15.12%	6,443 $403,000
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $159,382 - $176,465	2,236 Added 41.76%	7,591 $586,000
Q2 2018 Jul 25, 2018	SELL	$64.88 - $75.68 $24,135 - $28,152	-372 Reduced 6.5%	5,355 $379,000
Q1 2018 May 10, 2018	SELL	$72.84 - $88.8 $34,016 - $41,469	-467 Reduced 7.54%	5,727 $432,000
Q4 2017 Feb 08, 2018	BUY	$71.15 - $83.52 $14,087 - $16,536	198 Added 3.3%	6,194 $460,000
Q3 2017 Nov 02, 2017	BUY	$72.11 - $85.47 $19,686 - $23,333	273 Added 4.77%	5,996 $491,000
Q2 2017 Nov 01, 2017	BUY	N/A	135 Added 2.42%	5,723 $397,000
Q2 2017 Aug 14, 2017	SELL	N/A	-79 Reduced 1.39%	5,588 $387,000
Q1 2017 Nov 01, 2017	SELL	N/A	-592 Reduced 9.46%	5,667 $377,000
Q4 2016 Nov 01, 2017	BUY	N/A	6,259	6,259 $483,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rfg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rfg Advisory, LLC with notifications on news.

Account